Gene · 6311
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The TENT5A-ATXN2 axis modulates germline and somatic cell survival during heat stress. | Cell Death Dis | 2026 | 42443145 | PubTator, text mining | PubMed |
| Immune Activation and Glial Dysfunction in Spinocerebellar Ataxias: From Cerebellar Landscape to Disease-Driven Mechanisms and Immunomodulation. | Cerebellum | 2026 | 42426383 | PubTator, text mining | PubMed |
| Repeat expansions in Parkinson's disease and parkinsonism across ancestries: insights from a global genetic cohort. | medRxiv | 2026 | 42396269 | PubTator, text mining | PubMed |
| Integrative analysis of gastric tissue transcriptomes and gastric cancer GWAS implicates candidate susceptibility genes. | Am J Hum Genet | 2026 | 42392035 | PubTator, text mining | PubMed |
| Genome-wide spectrum of coding DNA variations in Indian patients with amyotrophic lateral sclerosis. | J Neurol | 2026 | 42384233 | PubTator, text mining | PubMed |
| Oligogenic variants in NEK1 and ATXN2 in amyotrophic lateral sclerosis: report of two cases and review of the literature. | Amyotroph Lateral Scler Frontotemporal Degener | 2026 | 42268660 | PubTator, text mining | PubMed |
| Genetic Variants and Clinical Characteristics of Young-Onset Parkinson's Disease in the Hakka Population of Western Fujian. | Brain Behav | 2026 | 42204920 | PubTator, text mining | PubMed |
| Computational Short Tandem Repeat Genotyping Reveals Clinically Relevant Expansions in a Large Turkish Neurodegeneration Disease Cohort. | Int J Mol Sci | 2026 | 42196324 | PubTator, text mining | PubMed |
| Identification of FGF14 GAA Expansions in Polish Patients with Undiagnosed Cerebellar Ataxia - A Preliminary Study. | Cerebellum | 2026 | 42096001 | PubTator, text mining | PubMed |
| Conserved role of Atx2 in JNK pathway activation. | Cell Death Dis | 2026 | 42069717 | PubTator, text mining | PubMed |
| The ATXN2 9 bp duplication in SCA3: clarifying evidence and correcting misinterpretations. | Acta Neuropathol Commun | 2026 | 42067958 | PubTator, text mining | PubMed |
| An integrated single-cell transcriptomics and explainable AI approach for cancer stemness biomarker discovery in non-small cell lung cancer. | Comput Biol Chem | 2026 | 42066389 | PubTator, text mining | PubMed |
| Peripheral lymphocyte subsets in spinocerebellar Ataxia type 2: Insights into disease mechanisms and potential immunomodulation. | J Neuroimmunol | 2026 | 42019185 | PubTator, text mining | PubMed |
| Corticospinal tract involvement in Spinocerebellar ataxias type 1, 2 and 3 characterized by motor evoked potentials and diffusion MRI. | Parkinsonism Relat Disord | 2026 | 42013783 | PubTator, text mining | PubMed |
| The relationship between level of education and disease onset and progression in spinocerebellar ataxia types 1, 2, 3, and 6. | Parkinsonism Relat Disord | 2026 | 41996746 | PubTator, text mining | PubMed |
| Pan-biological characteristics of ataxin-2 protein. | Neural Regen Res | 2026 | 41914075 | PubTator, text mining | PubMed |
| The Role of D/H Isotope Exchange in Stabilizing Trinucleotide Repeat Expansions in the CAG Tract of the ATXN2 Gene. | Dokl Biochem Biophys | 2026 | 41912844 | PubTator, text mining | PubMed |
| Lentiviral-induced Striatal Pathology as a Preclinical Model of Polyglutamine Spinocerebellar Ataxias. | J Vis Exp | 2026 | 41911156 | PubTator, text mining | PubMed |
| Emergence of Catalytic Activity in VRK3: Phosphoproteomic Insights into the Regulatory Network of a Former Pseudokinase. | Proteomes | 2026 | 41893729 | PubTator, text mining | PubMed |
| Genome-Wide Association Studies of Myocardial Infarction: A Systematic Literature Review. | J Cardiovasc Dev Dis | 2026 | 41892715 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6311/papers?page=2